Also known as Avapro
Irbesartan (INN) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro.Source: Wikipedia
DEA Class 4 meaning a low potential for abuse and low risk of dependence.
Estimated Total Cost: $72.65 for an average of 28 days supply
Patients are most commonly prescribed irbesartan to treat anemia due to chronic kidney disease, polycystic kidney disease, bladder obstruction, and polycythemia vera.